The public will have an opportunity to present their views to the Tick-Borne Disease Working Group Meeting on Jan 28-29. Verbal comments (in-person): Requests to provide verbal public comment must be submitted via email by midnight Tuesday, January 17, 2020, ET to tickbornedisease@hhs.gov. In the Subject line please enter: Verbal Public Comment – January 28-29 Meeting. In addition,
The National Science Advisory Board for Biosecurity (NSABB) will convene 23-24 January 2020 in Bethesda, Md. The meeting will be open to the public, with attendance limited to space available. The meeting will also be videocast. January 23: 12:30 PM – 5 PM Eastern January 24: 9 AM – 2:30 PM Eastern The purpose of
The National Academies' Forum on Drug Discovery, Development, and Translation will host a virtual public workshop on Jan 26, 2021 as part of a web series forum of events to discuss critical policy for advancement of biopharmaceutical innovation nationally and globally. This virtual public workshop will provide a venue for stakeholders to consider a transformed
The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City, Hubei Province, China. A number of countries, including the U.S., are actively screening incoming travelers from Wuhan. Starting January 21, 2020, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national
The 11th meeting of the Tick-borne Disease Working Group (TBDWG) will be held on January 28 and 29, 2020, from 9:00 a.m. to 4:30 p.m. ET on both days (times subject to change). The meeting will be held at the in Washington D.C. and by webcast. Preregistration for public members is advisable and can be
The leading annual conference on biodefense, biosecurity and biological threats, ASM Biothreats, will be held January 28–30, 2020 in Arlington, Virginia. Hosted by the American Society for Microbiology, this one-of-a-kind meeting draws stakeholders from government, academia and industry for an important exchange of knowledge and ideas that will shape the future of high consequence pathogen
Meeting registration will close on January 31, 2020 for the U.S. Trans-Agency Scientific Meeting on Developing Medical Countermeasures to Treat Acute and Chronic Effects of Ocular Chemical Toxicity. The meeting will be held Feb 25-26, 2020 at the NIAID Conference Center in Rockville, Md. The meeting is sponsored by the Chemical Countermeasures Research Program (CCRP),
The CDC will hold a COCA (Clinicians Outreach and Communication Activity) call this afternoon with their latest recommendations. Due to the high demand we anticipate for this COCA Call, we kindly ask participants to access it in a group format, if at all possible, to allow for the maximum number of participants to attend. Target audience: Physicians
The Medical Device Innovation Consortium (MDIC) will host a workshop on 3 Feb 2020 to explore key considerations for using real world data to help support in vitro diagnostic (IVD) products available under FDA’s emergency use authorization (EUA) to advance to full marketing status. A roadmap for diagnostic evaluations during emergencies would help enable stakeholders
